Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Inflammation in Hepatitis C
NCT01754961Phase 2Unknown
- Sponsor
- Veterans Medical Research Foundation
- Start
- Nov 2011
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatitis C (HCV) and Vitamin D deficiency (VDD) comparing Vitamin D with Placebo (2 arms). Primary endpoint: Macrophage activation at 1 week. Status: unknown.
02
Drugs
vitamin d
03
Conditions
hepatitis C (HCV)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01754961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01754961.